Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Feb 14, 2020

29745_dirs_2020-02-13_b500a0cb-1912-4455-81b8-fe01636d323c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-02-11

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-11 Common Stock A 77586 $144.25 Acquired 268252 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-11 Restricted Stock Unit $ A 75387 Acquired 2021-02-01 Common Stock (75387.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6563 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.